By increasing insulin secretion and suppressing glucagon secretion (through GLP-1 hormones), Ozempic can help to improve blood sugar regulation
If your doctor seems hesitant, ask whether they can refer you to an endocrinologist, obesity medicine specialist, or weight management clinic
Novo said last week that CagriSema was "well-tolerated" and that the most common adverse effects were gastrointestinal, but they were "mild to moderate and diminished over time." "Investors are looking for treatment options that are best in class and will secure Novo's place in the obesity drug market," Soren Lontoft, pharma equity analyst at Sydbank, told CNBC over the phone Tuesday
However, they are not prescribed as primary lipid-lowering agents and should complement established cholesterol management strategies
This approach provides an accessible pathway for patients who either do not qualify for insurance-covered treatment or prefer a private-pay, no-insurance-required model to manage their weight loss journey